Spero Therapeutics, Inc.SPRONASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank22
Studio
Year-over-Year Change

Return on equity

Latest
-148.66%
↑ 75% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-595.26%
Historical baseline
PeriodValueYoY Change
2024-148.66%-796.8%
202321.34%+134.9%
2022-61.13%+39.9%
2021-101.66%-71.5%
2020-59.29%+27.4%
2019-81.70%-127.2%
2018-35.96%+33.7%
2017-54.26%+78.4%
2016-250.67%+95.2%
2015-5180.61%-